Seite - (000263) - in Biomedical Chemistry: Current Trends and Developments

R.; Magdy, T.; Abdo, R.; Guterstam, P.; Sillard, R.; Hammond, S. M.; Wood, M. J. A.; Arzumanov, A. A.; Gait, M. J.; Smith, Ci. I. E.; Hällbrink, M.; Langel, Ü. (2011). pepFecr 14, a novel cell-penetrating peptide for oligonucleotide delivery in solution and as solid formulation. Nucleic Acids Research, 39, 5284-5298. Farrera-Sinfreu, J.; Giralt, E.; Castel, S.; Albericio, F.; Royo, M. (2005). Cell-penetrating cis-γ- amino-L-proline-derived peptides. Journal of the American Chemical Society, 127, 9459-9468. Fieck, A.; Hurwitz, I.; Kang, A. S.; Durvasula, R. (2010). Trypanosoma cruzi: Synergistic cytotoxicity of multiple amphipathic anti-microbial peptides to T. cruzi and potential bacterial hosts. Experimental Parasitology, 125, 342-347. Figueiredo, I. R.; Freire, J. M.; Flores, L.; Veiga, A. S. (2014). Castanho, M. A. R. B. Cell-penetrating peptides: a tool for effective delivery in gene-targeted therapies. IUBMB Life, 66, 182-194. Fleischer, S.; Dvir, T. (2013). Tissue engineering on the nanoscale: lessons from the heart. Current Opinion in Biotechnology, 24, 664-671. Fonseca, K. B.; Maia, F. R.; Cruz, F. A.; Andrade, D.; Juliano, M. A.; Granja, P. L.; Barrias, C. C. (2013). Enzymatic, physicochemical and biological properties of MMP-sensitive alginate hydrogels. Soft Matter, 9, 3283-3292. Frankel, A. D.; Pabo, C. O. (1988). Cellular uptake of the tat protein from Human Immunodeficiency virus. Cell, 55, 1189-1193. Futaki, S.; Suzuki, T.; Ohashi, W.; Yagami, T.; Tanaka, S.; Ueda, K.; Sugiura, Y. (2001). Arginine- rich peptides: An Abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. Journal of Biology Chemistry, 276, 5836-5840. Ganz, T.; Weiss, J. (1997). Antimicrobial peptides of phagocytes and epithelia, Seminars in Hematology, 34, 343-354. Gaston, M.A.; Zhang, L.; Green-Church, K. B.; Krzycki, J. A. (2011). The complete biosynthesis of the genetically encoded amino acids pyrrolysine from lysine. Nature, 471, 647-650. Gingrich, D. E.; Reddy, D. R.; Iqbal, M. A.; Singh, J.; Aimone, L. D.; Angeles, T. S.; Albom, M.; Yang, S.; Ator, M. A.; Meyer, S. L.; Robinson, C.; Ruggeri, B. A.; Dionne, C. A.; Vaught, J. L.; Mallamo, J. P.; Hudkins, R. L. (2003). A new class of potent vascular endothelial growth factor receptor tyrosine kinase inhibitors: structure-activity relationships for a series of 9- alkoxymethyl-12-(3-hydroxypropyl)indeno[2,1-a]pyrrolo[3,4-c] carbazole-5-ones and the identification of CEP-5214 and its dimethylglycine ester prodrug clinical candidate CEP-7055. Journal of Medicinal Chemistry, 46, 5375-5388. Gomes, P.; Gomes, J. R. B.; Rodrigues, M.; Moreira, R. (2003). Amino acids as selective sulfonamide acylating agents. Tetrahedron, 59, 7473-7480. Gomes, P.; Araújo, M. J.; Rodrigues, M.; Vale, N.; Azevedo, Z.; Iley, J.; Chambel, P.; Morais, J.; Moreira, R. (2004). Synthesis of imidazolidin-4-one and 1H-imidazo[2,1-a]isoindole- 2,5(3H,9bH)-dione derivatives of primaquine: scope and limitations. Tetrahedron, 60, 5551- 5562. Gomes, P.; Vale, N.; Moreira, R. (2007). Cyclization-activated prodrugs. Molecules, 12, 2484- 2506. Gonzalez, D. E.; Covitz, K-M. Y.; Sadée, W.; Mrsny, R. J.; (1998). An oligopeptide transporter is expressed at high levels in the pancreatic carcinoma cell lines AsPc-1 and Capan-2. Cancer Research, 58, 519-525. Goolcharran, C.; Borchardt, R. T. (1998). Kinetics of diketopiperazine formation using model